-
HEALTHCARE UTILIZATION FOR CERVICAL CANCER IN BRAZIL: A NATIONAL ANALYSIS OF OUTPATIENT AND INPATIENT CARE
Aug 11, 2026, 17:16 PM -
ENHANCING IMMUNIZATION COVERAGE MONITORING AFTER RECOMMENDATION CHANGES: THE VALUE AND CHALLENGES OF SURVEY-BASED PRIMARY DATA
Aug 11, 2026, 17:16 PM -
ECONOMICEVALUATION OF TISLELIZUMAB IN COMBINATION WITH GEMCITABINE AND CISPLATIN AS FIRST-LINETREATMENT IN PATIENTS WITH RECURRENT OR METASTATIC NASOPHARYNGEAL CANCER IN THAILAND
Aug 11, 2026, 17:16 PM -
FOOD NOISE DURING GLUCAGON-LIKE PEPTIDE-1 (GLP-1) MAINTENANCE: A SOCIAL MEDIA LISTENING ANALYSIS OF UK PATIENT COMMUNITIES
Aug 11, 2026, 17:16 PM -
AGENTIC ARTIFICIAL INTELLIGENCE AS A CO-DEVELOPER OF HEALTH ECONOMIC MODELS: APPLICATION TO A COST-EFFECTIVENESS ANALYSIS IN ADULT ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD)
Aug 11, 2026, 17:16 PM -
DETERMINING MEANINGFUL WITHIN-PATIENT CHANGE THRESHOLDS FOR GODDESS OUTCOMES IN THE PHASE 3 RINGSIDE PART B TRIAL
Aug 11, 2026, 17:16 PM -
WHEN EVIDENCE MOVES FASTER THAN GUIDELINES: MAINTAINING SYNCHRONIZATION ACROSS REGULATORY, CLINICAL, AND HTA MILESTONES IN BREAST CANCER (BC)
Aug 11, 2026, 17:16 PM -
OBSERVANCE OF ANTIFIBROTIC TREATMENT IN THE FRENCH OPALE SUPPORT PROGRAM FOR PATIENTS WITH PULMONARY FIBROSIS
Aug 11, 2026, 17:16 PM -
REVISITING THE PROGNOSTIC MEANING OF BODY MASS INDEX AFTER HFREF HOSPITALIZATION USING DAYS ALIVE AND OUT OF HOSPITAL: INSIGHTS FROM THE SINGCLOUD COHORT
Aug 11, 2026, 17:16 PM -
REAL-WORLD STUDY OF UPTAKE OF ENFORTUMAB VEDOTIN (EV) IN FIRST-LINE (1L) TREATMENT OF LOCALLY ADVANCED/METASTATIC UROTHELIAL CANCER (LA/MUC) IN THE US
Aug 11, 2026, 17:16 PM -
WEARABLE-DERIVED METRICS WERE ASSOCIATED WITH AIS SCORES AND DEMONSTRATED UTILITY IN MACHINE LEARNING-BASED CLASSIFICATION: THESE FINDINGS SUPPORT THE POTENTIAL OF WEARABLE-DERIVED METRICS AS DIGITAL BIOMARKERS OF INSOMNIA IN PATIENTS WITH RA
Aug 11, 2026, 17:16 PM -
MULTI-AI MODEL TRIAGE IN LITERATURE REVIEWS CONCENTRATES HUMAN REVIEW ON THE UNCERTAIN RECORDS AND RECOVERS THE FRONTIER MODEL'S SILENT MISSES
Aug 11, 2026, 17:16 PM -
BUDGET IMPACT OF ADDING ACORAMIDIS TO FORMULARY FOR THE TREATMENT OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY: A UNITED STATES HEALTH PLAN ANALYSIS
Aug 11, 2026, 17:16 PM -
IDENTIFICATION OF PRESCRIBING CENTERS FOR RARE DISEASE DRUGS IN ITALY: REGIONAL REGULATION AND PERCEIVED IMPACT ON ACCESS
Aug 11, 2026, 17:16 PM -
COST-UTILITY ANALYSIS OF DIGITAL BREAST TOMOSYNTHESIS FOR BREAST CANCER SCREENING IN KOREAN WOMEN
Aug 11, 2026, 17:16 PM -
TIME TO RESPOND? PROCEDURAL TIMELINES AND DEVELOPER PARTICIPATION IN EU JOINT CLINICAL ASSESSMENT
Aug 11, 2026, 17:16 PM -
STRUCTURED EXPERT ELICITATION TO INFORM COST SAVINGS POTENTIALS OF A VIRTUAL TWIN FOR CAR T-CELL THERAPY FOR MULTIPLE MYELOMA
Aug 11, 2026, 17:16 PM -
HEALTH-RELATED QUALITY OF LIFE (HRQOL), HUMANISTIC AND PRODUCTIVITY BURDEN OF CAREGIVERS OF CHILDREN RECENTLY DIAGNOSED WITH TYPE 1 DIABETES (T1D): A CROSS-SECTIONAL STUDY IN THE UNITED KINGDOM (UK)
Aug 11, 2026, 17:16 PM -
ANALYSIS OF DRUG REIMBURSEMENT LISTING RATES AND EVALUATION DURATIONS BY TYPE OF ASSESSMENT IN SOUTH KOREA (2007-2025)
Aug 11, 2026, 17:16 PM -
EXCESS HEALTHCARE RESOURCE UTILISATION AND DIRECT MEDICAL COSTS ASSOCIATED WITH POTENTIALCHLAMYDIA TRACHOMATIS-RELATED SEQUELAE IN GERMANY: A REAL-WORLD EVIDENCE STUDY COVERING 2010 TO 2022
Aug 11, 2026, 17:16 PM
